Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside
1996

Radiosensitivity of Human Pancreatic Tumor Cells and Sodium Nitroprusside

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): VN Verovski, DL Van den Berge, GA Soete, BL Bols, GA Storme

Primary Institution: Cancer Research Unit, Department of Radiotherapy, Oncology Center, Academic Hospital, Free University Brussels, Belgium

Hypothesis

Can sodium nitroprusside enhance the radiosensitivity of human pancreatic tumor cells?

Conclusion

Sodium nitroprusside is a potent radiosensitizer for hypoxic human pancreatic tumor cells.

Supporting Evidence

  • Sodium nitroprusside showed a mean enhancement ratio of 1.9 compared to oxygen.
  • The mean inactivation doses for the pancreatic tumor cells ranged from 2.4 to 6.5 Gy.
  • Radiosensitising activity correlated with the enhancement of single-strand DNA breakage caused by radiation.
  • Sodium nitroprusside was at least 10-fold more potent than etanidazole.
  • Radiosensitivity was assessed under both aerobic and hypoxic conditions.

Takeaway

This study found that a drug called sodium nitroprusside can help make certain cancer cells more sensitive to radiation treatment.

Methodology

The study assessed radiosensitivity using MTT assays and colony formation assays on eight human pancreatic tumor cell lines under various conditions.

Limitations

The study primarily focused on in vitro models, which may not fully represent in vivo conditions.

Participant Demographics

Human pancreatic tumor cell lines of ductal origin.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication